Quantitative fundus autofluorescence in healthy eyes

Investigative Ophthalmology and Visual Science

Volumn 54, Issue 8, 2013, Pages 5684-5693

  Greenberg, Jonathan P ^a   Duncker, Tobias ^a   Woods, Russell L ^b   Smith, R Theodore ^a,c   Sparrow, Janet R ^a   Delori, François C ^b  

^a Edward S Harkness Eye Institute   (United States)

^b SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^c NEW YORK UNIVERSITY   (United States)

Author keywords

Lipofuscin; Melanin; Quantitative fundus autofluorescence; Retina; Retinal pigment epithelium; Scanning laser ophthalmoscope

Indexed keywords

LIPOFUSCIN; MELANIN;

ADOLESCENT; ADULT; ARTICLE; AUTOFLUORESCENCE IMAGING; CHILD; COMPARATIVE STUDY; CONFOCAL SCANNING LASER OPHTHALMOSCOPE; ETHNICITY; EYE AXIS LENGTH; EYE FUNDUS; FEMALE; FLUOROPHOTOMETRY; HUMAN; IMAGE ANALYSIS; MALE; MEASUREMENT REPEATABILITY; NORMAL HUMAN; OPTICAL COHERENCE TOMOGRAPHY; OPTICAL DENSITY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RACE; REFRACTION ERROR; RETINA FOVEA;

LIPOFUSCIN; MELANIN; QUANTITATIVE FUNDUS AUTOFLUORESCENCE; RETINA; RETINAL PIGMENT EPITHELIUM; SCANNING LASER OPHTHALMOSCOPE;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CONTINENTAL POPULATION GROUPS; FEMALE; FUNDUS OCULI; HUMANS; LIPOFUSCIN; MALE; MELANINS; MIDDLE AGED; OPHTHALMOSCOPES; OPHTHALMOSCOPY; OPTICAL IMAGING; REFERENCE VALUES; RETINA; RETINAL PIGMENT EPITHELIUM; YOUNG ADULT;

EID: 84882770375     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.13-12445     Document Type: Article

References (77)

1. Delori FC, Dorey CK, Staurenghi G, Arend O, Goger DG, Weiter JJ. In vivo fluorescence of the ocular fundus exhibits retinal pigment epithelium lipofuscin characteristics. Invest Ophthalmol Vis Sci. 1995;36:718-729.
2. Eldred GE. Age pigment structure. Nature. 1993;364:396.
3. Parish CA, Hashimoto M, Nakanishi K, Dillon J, Sparrow JR. Isolation and one-step preparation of A2E and iso-A2E, fluorophores from human retinal pigment epithelium. Proc Natl Acad Sci U S A. 1998;95:14609-14613.
4. Fishkin N, Sparrow JR, Allikmets R, Nakanishi K. Isolation and characterization of a retinal pigment epithelial cell fluorophore: an all-trans-retinal dimer conjugate. Proc Natl Acad Sci U S A. 2005;102:7091-7096.
5. Wu Y, Fishkin NE, Pande A, Pande J, Sparrow JR. Novel lipofuscin bisretinoids prominent in human retina and in a model of recessive Stargardt disease. J Biol Chem. 2009;284: 20155-20166.
6. Yamamoto K, Yoon KD, Ueda K, Hashimoto M, Sparrow JR. A novel bisretinoid of retina is an adduct on glycerophosphoethanolamine. Invest Ophthalmol Vis Sci. 2011;52:9084-9090.
7. Wing GL, Blanchard GC, Weiter JJ. The topography and age relationship of lipofuscin concentration in the retinal pigment epithelium. Invest Ophthalmol Vis Sci. 1978;17:601-607.
8. Feeney-Burns L, Hilderbrand ES, Eldridge S. Aging human RPE: morphometric analysis of macular, equatorial, and peripheral cells. Invest Ophthalmol Vis Sci. 1984;25:195-200.
9. Weiter JJ, Delori FC, Wing GL, Fitch KA. Retinal pigment epithelial lipofuscin and melanin and choroidal melanin in human eyes. Invest Ophthalmol Vis Sci. 1986;27:145-151.
10. Boulton M, Docchio F, Dayhaw-Barker P, Ramponi R, Cubeddu R. Age-related changes in the morphology, absorption and fluorescence of melanosomes and lipofuscin granules of the retinal pigment epithelium. Vision Res. 1990;30:1291-1303.
11. Delori FC. Spectrophotometer for noninvasive measurement of intrinsic fluorescence and reflectance of the ocular fundus. Appl Optics. 1994;33:7439-7452.
12. Delori FC, Fleckner MR, Goger DG, Weiter JJ, Dorey CK. Autofluorescence distribution associated with drusen in agerelated macular degeneration. Invest Ophthalmol Vis Sci. 2000;41:496-504.
13. Spaide RF. Autofluorescence imaging with the fundus camera. In: Holz FG, Schmitz-Valckenberg S, Spaide RF, Bird AC, eds. Atlas of Fundus Autofluorescence Imaging. Berlin-Heidelberg, Germany: Springer-Verlag; 2007:49-54.
14. Morgan JI, Dubra A, Wolfe R, Merigan WH, Williams DR. In vivo autofluorescence imaging of the human and macaque retinal pigment epithelial cell mosaic. Invest Ophthalmol Vis Sci. 2009;50:1350-1359.
15. Webb RH, Hughes GW, Delori FC. Confocal scanning laser ophthalmoscope. Appl Optics. 1987;26:1492-1449.
16. von Ruckmann A, Fitzke FW, Bird AC. Distribution of fundus autofluorescence with a scanning laser ophthalmoscope. Br J Ophthalmol. 1995;79:407-412.
17. von Ruckmann A, Fitzke FW, Bird AC. Fundus autofluorescence in age-related macular disease imaged with a laser scanning ophthalmoscope. Invest Ophthalmol Vis Sci. 1997; 38:478-486.
18. Schmitz-Valckenberg S, Holz FG, Fitzke FW. Perspectives in imaging technologies. In: Holz FG, Schmitz-Valckenberg S, Spaide RF, Bird A, eds. Atlas of Fundus Imaging. Heidelberg, Germany: Springer-Verlag; 2007;331-338.
19. Lois N, Halfyard A, Bird AC, Fitzke FW. Quantitative evaluation of fundus autofluorescence imaged 'in vivo' in eyes with retinal disease. Br J Ophthalmol. 2000;84:741-745.
20. Delori FC, Goger DG, Dorey CK. Age-related accumulation and spatial distribution of lipofuscin in RPE of normal subjects. Invest Ophthalmol Vis Sci. 2001;42:1855-1866.
21. Cideciyan AV, Aleman TS, Swider M, et al. Mutations in ABCA4 result in accumulation of lipofuscin before slowing of the retinoid cycle: a reappraisal of the human disease sequence. Hum Mol Genet. 2004;13:525-534.
22. Greenstein VC, Duncker T, Holopigian K, et al. Structural and functional changes associated with normal and abnormal fundus autofluorescence in patients with retinitis pigmentosa. Retina. 2012;32:349-357.
23. Bindewald A, Schmitz-Valckenberg S, Jorzik JJ, et al. Classification of abnormal fundus autofluorescence patterns in the junctional zone of geographic atrophy in patients with age related macular degeneration. Br J Ophthalmol. 2005;89:874-878.
24. Holz FG, Bellman C, Staudt S, Schutt F, Volcker HE. Fundus autofluorescence and development of geographic atrophy in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2001;42:1051-1056.
25. Gelman R, Chen R, Blonska A, Barile G, Sparrow JR. Fundus autofluorescence imaging in a patient with rapidly developing scotoma. Retin Cases Brief Rep. 2012;6:345-348.
26. Robson AG, Egan CA, Luong VA, Bird AC, Holder GE, Fitzke FW. Comparison of fundus autofluorescence in photopic and scotopic fine-matrix mapping in patients with retinitis pigmentosa and normal visual acuity. Invest Ophthalmol Vis Sci. 2004;45:4119-4125.
27. Lois N, Halfyard AS, Bird AC, Holder GE, Fitzke FW. Fundus autofluorescence in Stargardt macular dystrophy-fundus flavimaculatus. Am J Ophthalmol. 2004;138:55-63.
28. Preising M. Fundus autofluorescence in Best disease. In: Lois N, Forrester JV, eds. Fundus Autofluorescence. Philadelphia, PA: Lippincott Williams and Wilkins; 2009:197-205.
29. Duncker T, Tabacaru MR, Lee W, Tsang SH, Sparrow JR, Greenstein VC. Comparison of near-infrared and shortwavelength autofluorescence in retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2013;54:585-591.
30. Delori FC, Greenberg JP, Woods RL, et al. Quantitative measurements of autofluorescence with the scanning laser ophthalmoscope. Invest Ophthalmol Vis Sci. 2011;52:9379-9390.
31. ANSI. American National Standard for Safe Use of Lasers (ANSI 136.1). Orlando: The Laser Institute of America; 2007.
32. Delori FC, Webb RH, Sliney DH. Maximum permissible exposures for ocular safety (ANSI 2000), with emphasis on ophthalmic devices. J Opt Soc Am A Opt Image Sci Vis. 2007; 24:1250-1265.
33. van de Kraats J, van Norren D. Optical density of the aging human ocular media in the visible and the UV. J Opt Soc Am A Opt Image Sci Vis. 2007;24:1842-1857.
34. Bland JM, Altman DG. Statistical method for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307-310.
35. Cideciyan AV, Swider M, Aleman TS, Roman MI, Sumaroka A, Schwartz SB. Reduced-illuminance autofluorescence imaging in ABCA4-associated retinal degenerations. J Opt Soc Am A Opt Image Sci Vis. 2007;24:1457-1467.
36. Delori FC, Burns SA. Fundus reflectance and the measurement of crystalline lens density. J Opt Soc Am A Opt Image Sci Vis. 1995;13:15-26.
37. Delori FC. RPE lipofuscin in ageing and age-related macular degeneration. In: Coscas G, Piccolino FC, eds. Retinal Pigment Epithelium and Macular Disease (Documenta Ophthalmologica). Dordrecht, The Netherlands: Kluwer Academic Publishers; 1995:37-45.
38. Baranoski GVG, Lam MWY. Qualitative assessment of undetectable melanin distribution in lightly pigmented irides. J Biomed Opt. 2007;12:030501.
39. Schmidt SY, Peisch RD. Melanin concentration in normal human retinal pigment epithelium. Invest Ophthalmol Vis Sci. 1986;27:1063-1067.
40. Imesch PD, Bindley CD, Khademian Z, et al. Melanocytes and iris color. Electron microscopic findings. Arch Ophthalmol. 1996;114:443-447.
41. Wielgus AR, Sarna T. Melanin in human irides of different color and age of donors. Pigment Cell Res. 2005;18:454-464.
42. Winn B, Whitaker D, Elliott DB, Phillips NJ. Factors affecting light-adapted pupil size in normal human subjects. Invest Ophthalmol Vis Sci. 1994;35:1132-1137.
43. van den Berg TJTP, Ijspeert JK, deWaard PWT. Dependence of intraocular straylight on pigmentation and light transmission through the ocular wall. Vision Res. 1991;31:1361-1367.
44. Coppens JE, Franssen L, van den Berg TJ. Wavelength dependence of intraocular straylight. Exp Eye Res. 2006;82: 688-692.
45. Wali N, Leguire LE. Fundus pigmentation and the dark-adapted electroretinogram. Doc Ophthalmol. 1992;80:1-11.
46. Nischler C, Michael R, Wintersteller C, et al. Iris color and visual functions. Graefes Arch Clin Exp Ophthalmol. 2013;25: 195-202.
47. Lorenz B, Wabbels B, Wegscheider E, Hamel CP, Drexler W, Presing MN. Lack of fundus autofluorescence to 488 nanometers from childhood on in patients with early-onset severe retinal dystrophy associated with mutations in RPE65. Ophthalmology. 2004;111:1585-1594.
48. Mata NL, Weng J, Travis GH. Biosynthesis of a major lipofuscin fluorophore in mice and humans with ABCR-mediated retinal and macular degeneration. Proc Natl Acad Sci U S A. 2000;97: 7154-7159.
49. Boyer NP, Higbee D, Currin MB, et al. Lipofuscin and Nretinylidene-N-retinylethanolamine (A2E) accumulate in the retinal pigment epithelium in the absence of light exposure: their origin is 11-cis retinal. J Biol Chem. 2012;287:22276-22286.
50. Sparrow JR, Gregory-Roberts E, Yamamoto K, et al. The bisretinoids of retinal pigment epithelium. Prog Retin Eye Res. 2012;31:121-135.
51. Wu Y, Yanase E, Feng X, Siegel MM, Sparrow JR. Structural characterization of bisretinoid A2E photocleavage products and implications for age-related macular degeneration. Proc Natl Acad Sci U S A. 2010;107:7275-7280.
52. Yoon KD, Yamamoto K, Ueda K, Zhou J, Sparrow JR. A novel source of methylglyoxal and glyoxal in retina: implications for age-related macular degeneration. PLoS One. 2012;7:e41309.
53. Duncker T, Greenberg JP, Sparrow JR, Smith RT, Quigley HA, Delori FC. Visualization of the optic fissure in shortwavelength autofluorescence images of the fundus. Invest Ophthalmol Vis Sci. 2012;53:6682-6686.
54. Okubo A, Rosa RHJ, Bunce CV, et al. The relationships of age changes in retinal pigment epithelium and Bruch's membrane. Invest Ophthalmol Vis Sci. 1999;40:443-449.
55. Age-Related Eye Disease Study Research Group. Risk factors associated with age-related macular degeneration. A casecontrol study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3. Ophthalmology. 2000; 107:2224-2232.
56. Naj AC, Scott WK, Courtenay MD, et al. Genetic factors in nonsmokers with age-related macular degeneration revealed through genome-wide gene-environment interaction analysis. Ann Hum Genet. 2013;77:215-231.
57. Rudnicka AR, Jarrar Z, Wormald R, Cook DG, Fletcher A, Owen CG. Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: a meta-analysis. Ophthalmology. 2012;119:571-580.
58. Klein R, Myers CE, Meuer SM, et al. Risk alleles in CFH and ARMS2 and the long-term natural history of age-related macular degeneration: the Beaver Dam Eye Study. JAMA Ophthalmol. 2013;131:383-392.
59. Klein R. Race/ethnicity and age-related macular degeneration. Am J Ophthalmol. 2011;152:153-154.
60. Hyman LG, Lilienfeld AM, Ferris FL, Fine SL. Senile macular degeneration: a case-control study. Am J Epidemiol. 1983;118: 213-227.
61. Holz FG, Piguet B, Minassian DC, Bird AC, Weale RA. Decreasing stromal iris pigmentation as a risk factor for agerelated macular degeneration. Am J Ophthalmol. 1994;117: 19-23.
62. Weiter JJ, Delori FC, Wing GL, Fitch KA. Relationship of senile macular degeneration to ocular pigmentation. Am J Ophthalmol. 1985;99:185-187.
63. Frank RN, Pukin JE, Stock C, Canter LA. Race, iris color, and age-related macular degeneration. Trans Am Ophthalmol Soc. 2000;98:109-117.
64. Chakravarthy U, Wong TY, Fletcher A, et al. Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis. BMC Ophthalmol. 2010;10:31.
65. Vinding T. Pigmentation of the eye and hair in relation to agerelated macular degeneration. An epidemiological study of 1000 aged individuals. Acta Ophthalmol. 1990;68:53-58.
66. Sandberg MA, Gaudio AR, Miller S, Weiner A. Iris pigmentation and extent of disease in patients with neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci. 1994;35: 2734-2740.
67. Spencer KL, Glenn K, Brown-Gentry K, Haines JL, Crawford DC. Population differences in genetic risk for age-related macular degeneration and implications for genetic testing. Arch Ophthalmol. 2912;130:116-117.
68. Martinez-Mir A, Paloma E, Allikmets R, et al. Retinitis pigmentosa caused by a homozygous mutation in the Stargardt disease gene ABCR. Nat Genet. 1998;18:11-12.
69. Shroyer NF, Lewis RA, Allikmets R, et al. The rod photoreceptor ATP-binding cassette transporter gene, ABCR, and retinal disease: from monogenic to multifactorial. Vision Res. 1999; 39:2537-2544.
70. Eagle RC, Lucier AC, Bernardino VB, Yanoff M. Retinal pigment epithelial abnormalities in fundus flavimaculatus. Ophthalmology. 1980;87:1189-1200.
71. Westeneng-van Haaften SC, Boon CJ, Cremers FP, Hoefsloot LH, den Hollander AI, Hoyng CB. Clinical and genetic characteristics of late-onset Stargardt's disease. Ophthalmology. 2012;119:1199-1210.
72. Frangieh GT, Green R, Fine SL. A histopatholgic study of Best's macular dystrophy. Arch Ophthalmol. 1982;100:1115-1121.
73. Bakall B, Radu RA, Stanton JB, et al. Enhanced accumulation of A2E in individuals homozygous or heterozygous for mutations in BEST1 (VMD2). Exp Eye Res. 2007;85:34-43.
74. Weingeist TA, Kobrin JL, Watzke RC. Histopathology of Best's macular dystrophy. Arch Ophthalmol. 1982;100:1108-1114.
75. O'Gorman S, Flaherty WA, Fishman GA, Berson EL. Histopathological findings in Best's vitelliform macular dystrophy. Arch Ophthalmol. 1988;106:1261-1268.
76. Spaide RF, Noble K, Morgan A, Freund KB. Vitelliform macular dystrophy. Ophthalmology. 2006;113:1392-1400.
77. Mullins RF, Kuehn MH, Faidley EA, Syed NS, Stone EM. Differential macular and peripheral expression of bestrophin in human eyes and its implication for Best disease. Invest Ophthalmol Vis Sci. 2007;48:3372-3380.